BIOMAT Database Logo BIOMAT Database Logo

[A clinical experience of ofloxacin in patients with respiratory infection]. 1989

K Tanaka, and H Suzuki, and S Shimizu, and H Otsuka, and H Takagi, and T Akisawa, and M Narushima, and H Tonotsuka, and H Kaneshige, and K Nakagami
Department of Respiratory Internal Medicine, Fujigaoka Hospital, Showa University.

To a total of 31 patients (18 in- and 13 out-patients) having respiratory infections, we administered ofloxacin (OFLX) orally at a daily dose of 300 to 600 mg and examined its clinical effect. The clinical effect in the 31 cases was as good as 83.9%. Among these cases, 6 cases showed Pseudomonas aeruginosa, thereby indicating the effective rate of OFLX at 50%. In the present examination, we experienced cases in which OFLX-resistant P. aeruginosa appeared in the cases of long-term administration of OFLX. Therefore, our clinic carried out the sensitivity test of P. aeruginosa against OFLX, gentamicin (GM) and imipenem (IPM) in 1987, using clinically-segregated strains of P. aeruginosa obtained by sputum tests. The sensitive strains, which were 100% sensitive to OFLX, GM, IPM respectively in 1985, showed, in segregated strains in 1987, sensitivity of OFLX 57.1%, GM 85.7% and IPM 100%, thus indicating the high resistance-acquiring frequency of P. aeruginosa against OFLX.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015242 Ofloxacin A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. DL-8280,DR-3355,Hoe-280,ORF-28489,Ofloxacin Hydrochloride,Ofloxacine,Ru-43280,Tarivid,DL 8280,DL8280,DR 3355,DR3355,Hoe 280,Hoe280,ORF 28489,ORF28489,Ru 43280,Ru43280

Related Publications

K Tanaka, and H Suzuki, and S Shimizu, and H Otsuka, and H Takagi, and T Akisawa, and M Narushima, and H Tonotsuka, and H Kaneshige, and K Nakagami
Overview of experience with ofloxacin in respiratory tract infection.
January 1990, Scandinavian journal of infectious diseases. Supplementum,
K Tanaka, and H Suzuki, and S Shimizu, and H Otsuka, and H Takagi, and T Akisawa, and M Narushima, and H Tonotsuka, and H Kaneshige, and K Nakagami
Clinical experience with ofloxacin in urinary tract infection.
January 1986, Infection,
K Tanaka, and H Suzuki, and S Shimizu, and H Otsuka, and H Takagi, and T Akisawa, and M Narushima, and H Tonotsuka, and H Kaneshige, and K Nakagami
[Clinical experience with ofloxacin in the treatment of chronic respiratory tract disease aggravated by acute infection].
September 1988, The Japanese journal of antibiotics,
K Tanaka, and H Suzuki, and S Shimizu, and H Otsuka, and H Takagi, and T Akisawa, and M Narushima, and H Tonotsuka, and H Kaneshige, and K Nakagami
Secretion of ofloxacin into saliva in patients with respiratory tract infection.
February 1992, International journal of clinical pharmacology, therapy, and toxicology,
K Tanaka, and H Suzuki, and S Shimizu, and H Otsuka, and H Takagi, and T Akisawa, and M Narushima, and H Tonotsuka, and H Kaneshige, and K Nakagami
[Respiratory tract infections--clinical results with ofloxacin].
January 1986, Infection,
K Tanaka, and H Suzuki, and S Shimizu, and H Otsuka, and H Takagi, and T Akisawa, and M Narushima, and H Tonotsuka, and H Kaneshige, and K Nakagami
A clinical experience with cefadroxil in upper respiratory tract infection.
September 1982, The Journal of antimicrobial chemotherapy,
K Tanaka, and H Suzuki, and S Shimizu, and H Otsuka, and H Takagi, and T Akisawa, and M Narushima, and H Tonotsuka, and H Kaneshige, and K Nakagami
Worldwide clinical experience with ofloxacin in urologic cases.
January 1991, Urology,
K Tanaka, and H Suzuki, and S Shimizu, and H Otsuka, and H Takagi, and T Akisawa, and M Narushima, and H Tonotsuka, and H Kaneshige, and K Nakagami
Clinical experience with ofloxacin in sexually transmitted disease.
January 1986, Infection,
K Tanaka, and H Suzuki, and S Shimizu, and H Otsuka, and H Takagi, and T Akisawa, and M Narushima, and H Tonotsuka, and H Kaneshige, and K Nakagami
Ofloxacin in respiratory tract infection. A review of the results of clinical trials in Japan.
January 1987, Drugs,
K Tanaka, and H Suzuki, and S Shimizu, and H Otsuka, and H Takagi, and T Akisawa, and M Narushima, and H Tonotsuka, and H Kaneshige, and K Nakagami
Fleroxacin versus ofloxacin in patients with complicated urinary tract infection: a controlled clinical study.
March 1993, The American journal of medicine,
Copied contents to your clipboard!